Vienna-based HeartBeat.bio raises €4.5 million to develop 3D human tissue-based drug discovery platform for heart disease

Published on November 3, 2023

HeartBeat.bio, a biotech company building a highly scalable human organoid and AI-supported drug discovery platform for heart disease, announced the closing of a €4.5 million pre-Series A round co-led by i&i Biotech Fund, Invest AG, aws Gründungsfonds II, and Tensor Ventures. The financing enables the completion of a ready-to-use, fully integrated, automated, high-throughput Cardioid Drug…

This content is for members only. Visit the site and log in/register to read.

The post Vienna-based HeartBeat.bio raises €4.5 million to develop 3D human tissue-based drug discovery platform for heart disease appeared first on EU-Startups.

Continue reading on website
Other news

Barcelona-based Kalma secures €1 million to facilitate the conversion of home equity into post-retirement liquidity for seniors

November 3, 2023
Kalma, a startup with social purposes that seeks to respond to the needs of those over 65 through innovative and revolutionary services, has closed its first round of financing amounting to €1 million. With the capital raised, the startup aims to consolidate and expand its business model. Kalma facilitates the conversion of home equity into… This content is for members only. Visit the site and log

Cambridge-based Nu Quantum secures €8 million to build the entanglement fabric essential to scale quantum computers

November 3, 2023
Nu Quantum, a Cambridge-based quantum networking company, announced that it has raised €8 million in a pre-series A round. The round is led by Amadeus Capital Partners, Expeditions Fund, and IQ Capital, with increased commitment from Seed investors Ahren Capital; Seraphim Capital; University of Cambridge and Martlet. New investors joining the round include Presidio Ventures… This content is for me